| Primary |
| Hiv Infection |
47.0% |
| Product Used For Unknown Indication |
24.4% |
| Prophylaxis Against Hiv Infection |
4.3% |
| Maternal Exposure Timing Unspecified |
3.5% |
| Hodgkin's Disease |
3.0% |
| Drug Exposure During Pregnancy |
2.5% |
| Drug Use For Unknown Indication |
2.5% |
| Prophylaxis |
2.1% |
| Systemic Antiviral Treatment |
1.6% |
| Blood Pressure Management |
1.3% |
| Maternal Exposure During Pregnancy |
1.1% |
| Tuberculosis |
1.1% |
| Antibiotic Prophylaxis |
1.0% |
| Vitamin Supplementation |
0.9% |
| Asthma |
0.8% |
| Antifungal Prophylaxis |
0.6% |
| Bone Tuberculosis |
0.6% |
| Hiv Infection Cdc Category A1 |
0.6% |
| Anaemia Of Pregnancy |
0.5% |
| Antiretroviral Therapy |
0.5% |
|
| Foetal Exposure During Pregnancy |
10.4% |
| Immune Reconstitution Syndrome |
9.6% |
| Abortion Spontaneous |
8.7% |
| Death |
7.0% |
| Diarrhoea |
7.0% |
| Stillbirth |
7.0% |
| Haematotoxicity |
6.1% |
| Anaemia |
5.2% |
| Premature Baby |
5.2% |
| Vomiting |
4.3% |
| Drug Exposure During Pregnancy |
3.5% |
| Extrapulmonary Tuberculosis |
3.5% |
| Intestinal Obstruction |
3.5% |
| Neurotoxicity |
3.5% |
| Abdominal Pain |
2.6% |
| Abortion Incomplete |
2.6% |
| Abortion Missed |
2.6% |
| Adrenal Disorder |
2.6% |
| Atrioventricular Block Complete |
2.6% |
| Blood Creatinine Increased |
2.6% |
|
| Secondary |
| Hiv Infection |
55.4% |
| Product Used For Unknown Indication |
8.3% |
| Antiretroviral Therapy |
7.9% |
| Prophylaxis Against Hiv Infection |
5.5% |
| Tuberculosis |
4.2% |
| Hypertension |
3.8% |
| Drug Exposure During Pregnancy |
3.5% |
| Blood Pressure Management |
2.3% |
| Antiviral Treatment |
1.4% |
| Malaria Prophylaxis |
1.1% |
| Systemic Antiviral Treatment |
1.1% |
| Foetal Exposure During Pregnancy |
0.9% |
| Antiviral Prophylaxis |
0.7% |
| Acquired Immunodeficiency Syndrome |
0.6% |
| Anti-infective Therapy |
0.6% |
| Drug Use For Unknown Indication |
0.6% |
| Hypertensive Crisis |
0.6% |
| Seminoma |
0.6% |
| Vaginal Discharge |
0.6% |
| Hepatitis B |
0.5% |
|
| Maternal Exposure During Pregnancy |
13.6% |
| Death |
9.3% |
| Premature Baby |
7.6% |
| Renal Failure Acute |
7.6% |
| Drug Exposure During Pregnancy |
5.1% |
| Gastroenteritis |
5.1% |
| Maternal Drugs Affecting Foetus |
5.1% |
| Vomiting |
5.1% |
| Abortion Spontaneous |
4.2% |
| Immune Reconstitution Syndrome |
4.2% |
| Patent Ductus Arteriosus |
4.2% |
| Plagiocephaly |
4.2% |
| Volvulus |
4.2% |
| Premature Rupture Of Membranes |
3.4% |
| Viral Mutation Identified |
3.4% |
| Weight Decreased |
3.4% |
| Asthenia |
2.5% |
| Atrial Septal Defect |
2.5% |
| Depressed Level Of Consciousness |
2.5% |
| Diarrhoea |
2.5% |
|
| Concomitant |
| Hiv Infection |
53.1% |
| Mycobacterium Avium Complex Infection |
10.0% |
| Prophylaxis |
4.1% |
| Product Used For Unknown Indication |
3.1% |
| Antiretroviral Therapy |
2.8% |
| Drug Exposure During Pregnancy |
2.8% |
| Acquired Immunodeficiency Syndrome |
2.5% |
| Lymphoma Aids Related |
2.5% |
| Meningitis Cryptococcal |
2.5% |
| Tuberculosis |
2.5% |
| Contraception |
2.2% |
| Antifungal Prophylaxis |
1.9% |
| Drug Use For Unknown Indication |
1.9% |
| Kaposi's Sarcoma Aids Related |
1.9% |
| Burkitt's Lymphoma |
1.3% |
| White Blood Cell Count Decreased |
1.3% |
| Hypothyroidism |
0.9% |
| Immunosuppression |
0.9% |
| Infection Prophylaxis |
0.9% |
| Medical Diet |
0.9% |
|
| Abortion Spontaneous |
18.2% |
| Nausea |
9.1% |
| Osteomalacia |
9.1% |
| Tachycardia |
7.3% |
| Foot Deformity |
5.5% |
| Convulsion |
3.6% |
| Disseminated Intravascular Coagulation |
3.6% |
| Foetal Death |
3.6% |
| Maternal Exposure During Pregnancy |
3.6% |
| Overdose |
3.6% |
| Pyrexia |
3.6% |
| Renal Failure Acute |
3.6% |
| Renal Tubular Necrosis |
3.6% |
| Thrombocytopenia |
3.6% |
| Treatment Noncompliance |
3.6% |
| Ultrasound Antenatal Screen Abnormal |
3.6% |
| Ventricular Septal Defect |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Acute Hepatic Failure |
1.8% |
| Anti-hbc Igg Antibody Positive |
1.8% |
|
| Interacting |
| Hypertension |
18.0% |
| Product Used For Unknown Indication |
15.8% |
| Hiv Infection |
13.5% |
| Antiretroviral Therapy |
12.8% |
| Drug Use For Unknown Indication |
12.8% |
| Immunosuppressant Drug Therapy |
8.3% |
| Hypercholesterolaemia |
5.3% |
| Burkitt's Lymphoma |
3.8% |
| Urinary Tract Infection |
2.3% |
| Vulvovaginal Candidiasis |
2.3% |
| Acquired Immunodeficiency Syndrome |
0.8% |
| Asthma |
0.8% |
| Bipolar Disorder |
0.8% |
| Hyperlipidaemia |
0.8% |
| Mania |
0.8% |
| Psychomotor Hyperactivity |
0.8% |
| Takayasu's Arteritis |
0.8% |
|
| Drug Interaction |
23.8% |
| Hypotension |
19.0% |
| Hepatotoxicity |
9.5% |
| Mania |
9.5% |
| Atrioventricular Block |
4.8% |
| Atrioventricular Block Complete |
4.8% |
| Drug Level Below Therapeutic |
4.8% |
| Extrapyramidal Disorder |
4.8% |
| Ileus Paralytic |
4.8% |
| Immunosuppressant Drug Level Increased |
4.8% |
| Renal Impairment |
4.8% |
| Rhabdomyolysis |
4.8% |
|
